CSGP vs ZYME · P/E 484, rev $2.74B vs rev $76.3M
CoStar Group Inc (CSGP) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the CSGP and ZYME stock pages for the full models.
Not investment advice.